文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

急诊科脓毒症团队实施后医院死亡率改善

Improved hospital mortality rates after the implementation of emergency department sepsis teams.
PubMed 文献 · Am J Emerg Med · 2021-10-25
一句话结论在三级急诊实施脓毒症团队后,脓毒症患者住院死亡率显著降低(校正OR 0.472,95%CI 0.352-0.632)。

本研究为回顾性研究,纳入某三级急诊就诊并被诊断为脓毒症和严重脓毒症的成年患者,比较实施急诊脓毒症团队前(2018年5月1日至2019年4月30日)与后(2019年11月1日至2020年9月30日,实施后设6个月洗脱期)的住院死亡率。共纳入1188例,实施前553例、实施后635例;平均年龄64岁,白人74.7%、黑人22.6%,Medicare最常见(59%)。控制Charlson合并症指数后,实施后死亡率显著降低,校正OR 0.472(95%CI 0.352-0.632);急诊停留时间、住院时间、乳酸检测时间和抗生素给药时间均显著缩短。

要点

  • 实施急诊脓毒症团队后,住院死亡率显著低于实施前,校正OR 0.472(95%CI 0.352-0.632),已控制Charlson合并症指数。
  • 脓毒症团队启动指征为:疑似感染且满足2项SIRS标准,或检查过程中确诊感染且满足2项SIRS标准。
  • 实施后急诊停留时间显著缩短(95%CI -67.2至-11.3),住院时间显著缩短(95%CI -1.0至-0.002)。
  • 实施后乳酸检测时间显著缩短(95%CI -10.0至-3.0),抗生素给药时间显著缩短(95%CI -29.0至-11.0)。
  • 研究为回顾性设计,实施后时段设6个月洗脱期,共纳入1188例成人脓毒症/严重脓毒症患者。

适用人群与场景

  • 在某三级急诊就诊并被诊断为脓毒症和严重脓毒症的成年患者。
  • 实施前时段为2018年5月1日至2019年4月30日,实施后时段为2019年11月1日至2020年9月30日,实施后设6个月洗脱期。

诊断标准与关键阈值

  • 脓毒症团队启动指征:疑似感染且满足2项全身炎症反应综合征(SIRS)标准,或检查过程中确诊感染且满足2项SIRS标准。

研究设计与关键结果

  • 研究类型为回顾性研究,共纳入1188例,实施前553例、实施后635例;平均年龄64岁,白人74.7%、黑人22.6%,Medicare最常见(59%)。
  • 实施后住院死亡率显著低于实施前,校正OR 0.472(95%CI 0.352-0.632),已控制Charlson合并症指数。
  • 实施后急诊停留时间显著缩短(95%CI -67.2至-11.3)。
  • 实施后住院时间显著缩短(95%CI -1.0至-0.002)。
  • 实施后乳酸检测时间显著缩短(95%CI -10.0至-3.0)。
  • 实施后抗生素给药时间显著缩短(95%CI -29.0至-11.0)。

证据类型、等级与局限

  • 证据类型:回顾性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,实施急诊脓毒症团队可降低住院患者死亡率、缩短急诊停留时间和住院时间。
  • 对符合启动指征(疑似或确诊感染且满足2项SIRS标准)的成人脓毒症患者,急诊脓毒症团队模式与更低的住院死亡率及更短的急诊停留时间、住院时间、乳酸检测时间和抗生素给药时间相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Sepsis is a leading cause of mortality with more than 700,000 hospitalizations and 200,000 deaths annually in the United States. Early recognition of sepsis is critical for timely initiation of treatment and improved outcomes. We sought to evaluate. in-hospital mortality rates of patients diagnosed with sepsis before and after implementation of emergency department (ED) sepsis teams.

METHODS: This was a retrospective study of adult patients seen at a tertiary care ED diagnosed with sepsis and severe sepsis. Pre-implementation study time frame was 5/1/2018-4/30/2019 and post-implementation was 11/1/2019-9/30/2020. A six-month washout period was utilized after implementation of ED-based sepsis teams. Indications for sepsis team activation were: two systemic inflammatory response syndrome (SIRS) criteria with suspected infection or two SIRS with confirmed infection during workup. Categorical variables are presented as frequencies and percentages. Continuous variables are presented as mean and standard deviation or median and quartiles depending on distribution. Multiple logistic regression compared mortality rates pre- and post-implementation while controlling for Charlson comorbidity index. Secondary objectives included comparing time metrics pre- and post-implementation. Student t-tests compared normally distributed variables and Wilcoxon rank sum tests compared non-normally distributed variables.

RESULTS: There were 1188 participants included in the study; 553 before implementation of sepsis teams and 635 after implementation. Mean age of participants was 64 years. Patients were 74.7% white and 22.6% black. Medicare was the most common health insurance (59%). Mortality rates were significantly lower post-implementation of sepsis teams compared to pre-implementation with an adjusted odds ratio of 0.472, (95%CI, 0.352-0.632). ED LOS (95%CI (-67.2--11.3), hospital LOS (95%CI, -1.0--0.002) and time to lactic acid (95%CI, -10.0- -3.0) and antibiotics (95%CI, -29.0--11.0) were all significantly lower after implementation.

CONCLUSION: Implementation of ED sepsis teams decreased inpatient hospital mortality rates, ED length of stay and hospital length of stay.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Simon EL, Truss K, Smalley CM, et al. Improved hospital mortality rates after the implementation of emergency department sepsis teams. Am J Emerg Med. 2021. PMID: 34775195. doi:10.1016/j.ajem.2021.10.035

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。